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limited the development of specific treatment whereas the gold standard treat-
ment is little tolerated. In the context of cardiomyocytes death or life, this
study purposes to investigate the role of endoplasmic reticulum (ER) stress
and hypoxia inducible factor-1 (HIF-1) in myocardial susceptibility to
ischemia-reperfusion (I/R) induced by chronic IH.
Methods: C57Bl6J, HIF-1α+/– and their control mice were exposed to
14 days of IH (21–5% FiO2, 60s cycle, 8h/day). Then, mice were submitted
to an in vivo ischemia-reperfusion to assess infarct size (IS, in % relative to
area at risk) or hearts were removed to assess ER stress markers and HIF-1
activity using Western-blot and ELISA. In additional groups, TUDCA (an ER
stress inhibitor, 75mg. kg-1) was administered daily during N or IH exposition
to assess the role of ER stress in IH-susceptibility to I/R.
Results: Whereas chronic IH induced an increase in infarct size (33.7±9.4
vs 61.0±5.6% in N and IH groups, respectively, p<0.05), IH failed to increase
infarct size in HIF1α+/- mice (42.4±2.7 vs 24.7±3.4 % in HIF1α+/- -N and
HIF1α+/- -IH, respectively). An increase in HIF-1 activity and ER stress
markers was also observed in IH-mice. By the way, TUDCA totally abolished
the IH-increased in infarct size (49.9±3.0 vs 61.0±5.6% in IH-TUDCA,
respectively) as well as the IH-increased in HIF-1 activity (1.3±0.04 vs
0.14±0.02 fold increase in IH and IH/TUDCA, p<0.0001 vs non treated mice).
Conclusion: These results suggest that the “ER stress-HIF-1“axe should be
considered in apneic patients as a potential therapeutic target to limit myocar-
dial ischemic damages.
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Introduction: Ultra-fast cooling induced by total liquid ventilation (TLV)
has been shown to be potently neuro and cardioprotective after shockable car-
diac arrest and/or acute myocardial infarction. In this study we examined a
possible underlying mechanism of this protection, in particular reduced free
radicals production.
Methods and Results: Thirty six rabbits subjected to asphyxia cardiac
arrest were divided into three groups: normothermic life support (Control
group, n=12) or hypothermia induced by either i.v. cold saline (CONV group;
n=12) or by TLV (TLV group, n=12). Using electronic paramagnetic reso-
nance spectroscopy (EPR) and 1-hydroxy-3-methoxycarbonyl-2,2,5,5-tetra-
methylpyrrolidine hydrochloride (CMH) as spin probe, we observed a
decrease in the production of free radicals in various organs including the
heart and the cerebral cortex in TLV and CONV groups as compared to
Control, however the effect of TLV was significantly more marked. These
results were associated with a significant improvement of the neurological
status and an increase in the survival rate as compared to Control and CONV
groups.
Conclusion: Therapeutic hypothermia induced by TLV could be a pro-
mising approach to improve organ preservation before irreversible alteration
by free radicals.
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Introduction: In this study, we aimed at testing the therapeutic potential
of a novel Natriuretic Peptide (NPs), identified from Tunisian snake venom,
when administered during reperfusion.
Materials and Methods: Langendorff perfused male Wistar rat hearts
were subjected to 30min regional coronary artery occlusion followed by
90min reperfusion. Hearts were treated either with brain natriuretic peptide
BNP (10nM) or NPs (200nM). In another set of experiments, hearts were pre-
treated with either isatin (100μM), a natriuretic peptide receptors blocker or
5HD (10μM), a mitochondrial KATP channels blocker. Post ischemic cardiac
haemodynamic parameters, using Labt Chart (ADInstruments) and infarct size
(IS), using planimetry, were evaluated. Western blotting experiments for
studying cGMP and Reperfusion Injury Salvage Kinases pathways were per-
formed. Calcium Retention Capacity (CRC) to evaluate the mitochondrial
function was also assessed by oxygraphy.
Results: BNP and NPs significantly decreased the IS by 60% and 62%
respectively compared to control non treated hearts (p<0.001). Regarding
hemodynamic parameters, both BNP and NPs improved the developed pres-
sure (DP) by 135 % and 152 % respectively (p<0.05). These beneficial effects
are abolished after pretreatment by isatin or 5HD. NPs significantly increased
the expression of pAKT, pGSK3ß and PKCε  when BNP increased pERK1/2
compared to control group. Both BNP and NPs increased the CRC by 124%
and 86% respectively compared to control group.
Conclusion: Our results demonstrate that NPs and BNP have cardioprotec-
tive effects during acute myocardial ischemia. These effects are mediated, for
both drugs, by natriuretic receptors and by the activation of mitochondrial
KATP channels. The cardioprotection involves the two PI3K/Akt/ERK and
cGMP-PKC signaling pathways which converge to the mitochondria. Admin-
istration of NPs may provide a novel therapeutic strategy in acute myocardial
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